Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines
- 21 June 2006
- Vol. 353 (1) , 6-16
- https://doi.org/10.1016/j.virol.2006.03.049
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccineVaccine, 2005
- Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entryBiochemical and Biophysical Research Communications, 2004
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragmentsBiochemical and Biophysical Research Communications, 2004
- Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A geneGene Therapy, 2004
- Codon Usage Optimization of HIV Type 1 Subtype Cgag,pol,env, andnefGenes:In VitroExpression and Immune Responses in DNA-Vaccinated MiceAIDS Research and Human Retroviruses, 2003
- Use of adeno-associated viral vector for delivery of small interfering RNAOncogene, 2003
- The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core ComplexJournal of Virology, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003